je.st
news
Bristol-Myers Squibb Shifts R&D Focus
2013-11-09 00:37:56| Biotech - Topix.net
Bristol-Myers Squibb will now focus on the late-stage development and commercialization of its diabetes franchise and its hepatitis C drugs.
Tags: focus
shifts
squibb
bristolmyers
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|